Triazolam and Decadron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triazolam (triazolam) and Decadron (dexamethasone). Common drug interactions include anaemia among females and disseminated intravascular coagulation among males.

The phase IV clinical study analyzes what interactions people have when they take Triazolam and Decadron. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Triazolam?

Triazolam has active ingredients of triazolam. It is often used in insomnia. eHealthMe is studying from 5,838 Triazolam users. Check the latest studies of Triazolam.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.



On Jul, 04, 2026

20 people who take Triazolam and Decadron together, and have interactions are studied.

Triazolam and Decadron drug interactions.

What are the common drug interactions of Triazolam and Decadron, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Pleural effusion (water on the lungs)
  5. Platelet count decreased
  6. Hypertension (high blood pressure)
  7. Diarrhoea
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  10. Blood cholesterol increased

male:

  1. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  2. Infection
  3. Irritable bowel syndrome
  4. Renal failure acute (rapid kidney dysfunction)
  5. Restless legs syndrome (a powerful urge to move your legs)
  6. Confusional state
  7. Disturbance in attention
  8. Dizziness
  9. Dyspnoea (difficult or laboured respiration)
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Triazolam and Decadron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hypertension (high blood pressure)
  2. Diarrhoea
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Blood cholesterol increased
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Glaucoma (increased fluid pressure in the eye with vision loss)
  8. Neuropathy peripheral (surface nerve damage)
  9. Purpura senile (skin condition in which areas of the skin develop a purplish or reddish-brown appearance due to bleeding of small blood vessels underneath)
  10. Renal failure (kidney dysfunction)

40-49:

n/a

50-59:

  1. Adjustment disorder with depressed mood
  2. Colonoscopy
  3. Cough
  4. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  5. Drug ineffective
  6. Irritable bowel syndrome
  7. Restless legs syndrome (a powerful urge to move your legs)

60+:

  1. Anaemia (lack of blood)
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Renal failure acute (rapid kidney dysfunction)
  5. Confusional state
  6. Disturbance in attention
  7. Dizziness
  8. Dyspnoea (difficult or laboured respiration)
  9. Fatigue (feeling of tiredness)
  10. Hypoaesthesia (reduced sense of touch or sensation)

What are the existing conditions these people have? *

  1. High Blood Pressure: 6 people, 30.00%
  2. Constipation: 5 people, 25.00%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 25.00%
  4. Cancer Pain: 5 people, 25.00%
  5. Gastric Cancer (stomach cancer): 3 people, 15.00%
  6. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 3 people, 15.00%
  7. Lung Cancer - Non-Small Cell (lung cancer): 3 people, 15.00%
  8. Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 3 people, 15.00%
  9. Oedema (fluid collection in tissue): 2 people, 10.00%
  10. Gastric Ulcer (stomach ulcer): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Triazolam and Decadron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Triazolam and Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Triazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Triazolam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Decadron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on triazolam and dexamethasone (the active ingredients of Triazolam and Decadron, respectively), and Triazolam and Decadron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: